Booster for Ranbaxy as Glaxo`s Augmentin plea is rejected by US court
The US Court of Appeals for the Federal Circuit Wsahington, DC, on Friday rejected GlaxoSmithKline Plc's bid to salvage patent protection for its antibiotic Augmentin, once its second-biggest selling